Table 2.

Effect of GCV treatment on pathology scores in recipients of IL-4-tk spleen cells

OrganGroup
BM (PBS) (4)BM (GCV) (4)Tg (PBS) (4)Tg (GCV) (4)IL-4-tk (PBS) (7)IL-4-tk (GCV) (7)
Liver 0.5 ± 0.6 1 ± 0.5 1 ± 0.5 1 ± 0.5 1 ± 0.5 0 ± 1.6 
Colon 0 ± 1 0 ± 0 1 ± 0.5 1.5 ± 0.6 2 ± 0.8 0 ± 0.8* 
Small intestine 0.5 ± 0.6 0.5 ± 1 0 ± 1 1.5 ± 1 1 ± 0.5 1 ± 1 
Skin 0 ± 0.5 0 ± 0.8 2.5 ± 1.7 3.5 ± 3.3 4.5 ± 2.2 0 ± 1.6 
Ear 0.5 ± 0.96 1 ± 1.2 4.5 ± 1 6.5 ± 3.5 5 ± 2.4 2 ± 2.1 
Tongue 0 ± 0.58 0 ± 1 3.5 ± 1.9 4 ± 0.6 0 ± 1.7 0 ± 1.6 
OrganGroup
BM (PBS) (4)BM (GCV) (4)Tg (PBS) (4)Tg (GCV) (4)IL-4-tk (PBS) (7)IL-4-tk (GCV) (7)
Liver 0.5 ± 0.6 1 ± 0.5 1 ± 0.5 1 ± 0.5 1 ± 0.5 0 ± 1.6 
Colon 0 ± 1 0 ± 0 1 ± 0.5 1.5 ± 0.6 2 ± 0.8 0 ± 0.8* 
Small intestine 0.5 ± 0.6 0.5 ± 1 0 ± 1 1.5 ± 1 1 ± 0.5 1 ± 1 
Skin 0 ± 0.5 0 ± 0.8 2.5 ± 1.7 3.5 ± 3.3 4.5 ± 2.2 0 ± 1.6 
Ear 0.5 ± 0.96 1 ± 1.2 4.5 ± 1 6.5 ± 3.5 5 ± 2.4 2 ± 2.1 
Tongue 0 ± 0.58 0 ± 1 3.5 ± 1.9 4 ± 0.6 0 ± 1.7 0 ± 1.6 

Shown are means ± SD of scores from each indicated group. Numbers of mice in each are given in parenthesis after the group name.

*

P < .05.

or Create an Account

Close Modal
Close Modal